Insider 10b5-1 sales reported for NTRA (NTRA) including 33,600 shares

Rhea-AI Filing Summary

NTRA files a Form 144 reporting proposed insider sales of Common Stock. The notice lists a 10b5-1 sale of 33,600 shares for $8,455,352.64 on 06/24/2026, plus earlier 10b5-1 transactions of 1,861 shares for $379,811.07 on 04/27/2026 and 330 shares for $68,032.80 on 05/01/2026. The form also references 16,800 shares from previously exercised options dated 01/14/2022.

Insights

Securities Compliance Analyst

Form 144 documents scheduled insider dispositions, including a large 10b5-1 sale.

The filing lists specific proposed sales: 33,600 shares ($8,455,352.64) on 06/24/2026 and smaller 10b5-1 transactions on 04/27/2026 and 05/01/2026. These entries are routine notifications required when insiders plan sales.

Timing and method are shown as 10b5-1 plan sales for the named individual; cash‑flow treatment and beneficiary details are not provided in the excerpt. Subsequent public filings may show actual settlement and any change in holdings.

Key Figures

10b5-1 sale: 33,600 shares Proceeds reported: $8,455,352.64 10b5-1 sale: 1,861 shares +4 more

7 metrics

10b5-1 sale 33,600 shares 06/24/2026

Proceeds reported $8,455,352.64 proceeds tied to 33,600 shares on 06/24/2026

10b5-1 sale 1,861 shares 04/27/2026

Proceeds reported $379,811.07 proceeds tied to 1,861 shares on 04/27/2026

10b5-1 sale 330 shares 05/01/2026

Proceeds reported $68,032.80 proceeds tied to 330 shares on 05/01/2026

Previously exercised options 16,800 shares 01/14/2022

Key Terms

10b5-1, Form 144, Previously Exercised Stock Options

3 terms

10b5-1 regulatory

"10b5-1 Sales for DANIEL RABINOWITZ 13011 McCallen Pass"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Previously Exercised Stock Options financial

"Previously Exercised Stock Options | Issuer | 16800 | 01/14/2022"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/01/2026 - 04:16 PM Accepted by SEC EDGAR 07/01/2026 - 04:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	16800	4560360.00	143215382	07/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/14/2022	Previously Exercised Stock Options	Issuer			16800	01/14/2022	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL RABINOWITZ 13011 McCallen Pass, Bldg A Suite 100 Austin TX 78753	Common	06/24/2026	33600	8455352.64
DANIEL RABINOWITZ 13011 McCallen Pass, Bldg A Suite 100 Austin TX 78753	Common	05/01/2026	330	68032.80
DANIEL RABINOWITZ 13011 McCallen Pass, Bldg A Suite 100 Austin TX 78753	Common	04/27/2026	1861	379811.07

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NTRA Form 144 report show?

The Form 144 reports proposed insider dispositions of Common Stock. It lists a 10b5-1 sale of 33,600 shares for $8,455,352.64 on 06/24/2026 and two earlier 10b5-1 sales on 04/27/2026 and 05/01/2026.

Who is named on the Form 144 for NTRA?

The filing identifies Daniel Rabinowitz as the reporting person for the 10b5-1 transactions. The excerpt shows his address and the dated sales of 1,861, 330, and 33,600 shares respectively.

Were the sales executed under a trading plan?

Yes. The excerpt explicitly labels the listed transactions as 10b5-1 sales, indicating they were scheduled under a prearranged trading plan rather than ad-hoc open-market trades on the filing dates shown.

Does the Form 144 show proceeds from the sales?

The filing lists dollar amounts tied to each sale: $379,811.07 for 1,861 shares, $68,032.80 for 330 shares, and $8,455,352.64 for 33,600 shares. It does not state use of proceeds in the excerpt.

What is the significance of the 16,800-share line dated 01/14/2022?

The excerpt references 16,800 shares associated with previously exercised stock options dated 01/14/2022. That line appears to document the grant/exercise origin of shares but does not itself state a current sale execution.